HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ursula Creutzig Selected Research

ICE protocol 4

8/2015Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial.
1/2012The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study.
6/2010Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
5/2010Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse.
9/2006Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
11/2004Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ursula Creutzig Research Topics

Disease

36Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2021 - 05/2003
8Neoplasms (Cancer)
01/2020 - 03/2002
6Down Syndrome (Down's Syndrome)
10/2018 - 01/2002
5Infections
10/2016 - 11/2004
5Leukemia
04/2009 - 01/2002
4Acute Promyelocytic Leukemia
12/2017 - 05/2003
3Myeloid Leukemia (Leukemia, Myelocytic)
10/2018 - 01/2016
3Cardiotoxicity
07/2013 - 06/2007
3Neutropenia
04/2009 - 09/2006
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2006 - 01/2002
2Residual Neoplasm
10/2018 - 01/2005
2Liver Diseases (Liver Disease)
10/2018 - 03/2008
2Cardiomyopathies (Cardiomyopathy)
07/2013 - 06/2007
2Febrile Neutropenia
04/2009 - 02/2007
1Ascites
10/2018
1Hydrops Fetalis (Fetal Edema)
10/2018
1Pneumonia (Pneumonitis)
10/2016
1Gastroenteritis
10/2016
1Bacteremia
10/2016
1Fever of Unknown Origin
10/2016
1Breast Neoplasms (Breast Cancer)
02/2016
1Disease Progression
01/2016
1Chromosome Aberrations (Chromosome Abnormalities)
06/2010
1Lymphoma (Lymphomas)
04/2009
1Pain (Aches)
06/2008
1Thrombocytopenia (Thrombopenia)
03/2008
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2006
1Hyperbilirubinemia
05/2003
1Hypotension (Low Blood Pressure)
05/2003

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
01/2017 - 01/2002
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2010 - 12/2004
4Cytarabine (Cytosar-U)FDA LinkGeneric
10/2018 - 12/2004
3Proteins (Proteins, Gene)FDA Link
02/2016 - 06/2004
3AnthracyclinesIBA
07/2013 - 06/2007
3Daunorubicin (Cerubidine)FDA LinkGeneric
07/2013 - 06/2007
3Core Binding Factors (Core-Binding Factor)IBA
11/2011 - 03/2011
2Gemtuzumab (Mylotarg)FDA Link
01/2019 - 05/2003
2Anti-Bacterial Agents (Antibiotics)IBA
10/2016 - 04/2009
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
02/2016 - 06/2006
2fludarabineIBA
01/2006 - 12/2004
1Arsenic Trioxide (Trisenox)FDA Link
08/2017
1RetinoidsIBA
08/2017
1AcidsIBA
08/2017
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
02/2016
1multidrug resistance-associated protein 3IBA
02/2016
1VorinostatFDA Link
01/2016
1Histone Deacetylase InhibitorsIBA
01/2016
1Histone Deacetylases (Histone Deacetylase)IBA
01/2016
1GlucocorticoidsIBA
01/2016
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
07/2013
1Nuclear Pore Complex Proteins (Nucleoporins)IBA
09/2011
1nuclear pore complex protein 98IBA
09/2011
1CCAAT-Enhancer-Binding ProteinsIBA
03/2011
1Biological ProductsIBA
03/2011
1Tyrosine Kinase InhibitorsIBA
10/2010
1SU 11657IBA
10/2010
1Protein Isoforms (Isoforms)IBA
05/2010
1Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA
05/2010
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2009
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
04/2009
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
04/2009
1Cytochromes c (Cytochrome c)IBA
03/2008
1Caspase 3 (Caspase-3)IBA
03/2008
1Vascular Endothelial Growth Factor CIBA
02/2008
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2008
1Antineoplastic Agents (Antineoplastics)IBA
06/2007
1CladribineFDA LinkGeneric
01/2006
1TransferasesIBA
11/2005
1tipifarnib (R115777)IBA
11/2005
1AntigensIBA
01/2005
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2005
1X-Linked Inhibitor of Apoptosis ProteinIBA
06/2004
1SurvivinIBA
06/2004
1Transaminases (Aminotransferases)IBA
05/2003
1Tretinoin (Retinoic Acid)FDA LinkGeneric
05/2003

Therapy/Procedure

12Therapeutics
05/2021 - 04/2003
12Drug Therapy (Chemotherapy)
01/2019 - 03/2002
6ICE protocol 4
08/2015 - 11/2004
4Stem Cell Transplantation
01/2019 - 06/2008
3Hematopoietic Stem Cell Transplantation
01/2020 - 12/2017
1Salvage Therapy
01/2019
1Aftercare (After-Treatment)
04/2003